Arkolith/Insider Trading/SNTI

SNTI Insider Trading

SNTI · full profile →Last filing Mar 9, 2026
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

77 shown
DateInsiderRoleActionSharesPriceValue
Mar 9, 2026Lu Timothy KCEO, DirectorTax withholding(F)81K—$0
Mar 9, 2026Rajangam KanyaPres. & Chief Med. & Dev. Off.Tax withholding(F)11K—$0
Feb 2, 2026Lu Timothy KCEO, DirectorTax withholding(F)4K—$0
Feb 2, 2026Rajangam KanyaPres. & Chief Med. & Dev. Off.Tax withholding(F)1K—$0
Jul 18, 2025Baum Bryan DanielDirectorGrant(A)44K—$0
Jun 25, 2025Mathers Edward TDirectorGrant(A)22K—$0
Jun 25, 2025Tang Donald FDirectorGrant(A)22K—$0
Jun 25, 2025Cooperstone BrendaDirectorGrant(A)22K—$0
Jun 25, 2025Schulz FranDirectorGrant(A)22K—$0
Jun 25, 2025Hsiung FengDirectorGrant(A)22K—$0
Jun 25, 2025Collins James J.DirectorGrant(A)22K—$0
Mar 10, 2025Florence Anthony A. Jr.10% OwnerConversion(C)3.3M——
Mar 10, 2025Florence Anthony A. Jr.10% OwnerConversion(C)3K——
Mar 10, 2025Celadon Partners SPV 2410% OwnerConversion(C)9.8M——
Mar 10, 2025Celadon Partners SPV 2410% OwnerConversion(C)10K——
Mar 10, 2025Bayer US Holding LP10% OwnerConversion(C)2.2M——
Mar 10, 2025Bayer US Holding LP10% OwnerConversion(C)2K——
Mar 10, 2025Rajangam KanyaPres. & Chief Med. & Dev. Off.Conversion(C)33K$2.25$74K
Mar 10, 2025Rajangam KanyaPres. & Chief Med. & Dev. Off.Conversion(C)33$2,250.00$74K
Mar 7, 2025Mathers Edward TDirectorGrant(A)44K—$0
Mar 7, 2025Lu Timothy KCEO and Interim PFO and PAO, DirectorGrant(A)642K—$0
Mar 7, 2025Rajangam KanyaPres. & Chief Med. & Dev. Off.Grant(A)78K—$0
Mar 7, 2025Cross John Harry IIIChief Financial OfficerGrant(A)174K—$0
Mar 7, 2025Hsiung FengDirectorGrant(A)44K—$0
Mar 7, 2025Cooperstone BrendaDirectorGrant(A)44K—$0
Mar 7, 2025Tang Donald FDirectorGrant(A)44K—$0
Mar 7, 2025Collins James J.DirectorGrant(A)44K—$0
Mar 7, 2025Schulz FranDirectorGrant(A)44K—$0
Mar 6, 2025Lu Timothy KCEO and Interim PFO and PAO, DirectorGrant(A)1.9M—$0
Mar 6, 2025Rajangam KanyaPres. & Chief Med. & Dev. Off.Grant(A)235K—$0
Feb 6, 2025Rajangam KanyaPres. & Chief Med. & Dev. Off.Sell(S)182$4.37$795
Feb 6, 2025Lu Timothy KCEO, DirectorSell(S)545$4.36$2K
Feb 4, 2025Rajangam KanyaPres. & Chief Med. & Dev. Off.Sell(S)1K$4.07$5K
Feb 4, 2025Lu Timothy KCEO, DirectorSell(S)4K$4.07$16K
Dec 9, 2024Bayer US Holding LP10% OwnerBuy(P)2K——
Dec 9, 2024Bayer US Holding LP10% OwnerBuy(P)3.3M——
Dec 9, 2024Rajangam KanyaPres. & Chief Med. & Dev. Off.Grant(A)33$2,250.00$74K
Dec 9, 2024Rajangam KanyaPres. & Chief Med. & Dev. Off.Grant(A)50K—$0
Dec 9, 2024Schulz FranDirectorGrant(A)13K—$0
Dec 9, 2024Tang Donald FDirectorGrant(A)13K—$0
Jul 10, 2024Mathers Edward TDirectorGrant(A)63K—$0
Jul 10, 2024Cooperstone BrendaDirectorGrant(A)63K—$0
Jul 10, 2024Collins James J.DirectorGrant(A)63K—$0
Jul 10, 2024Farokhzad OmidDirectorGrant(A)63K—$0
Feb 1, 2024Knobelman DeborahChief Financial OfficerGrant(A)101K—$0
Feb 1, 2024Knobelman DeborahChief Financial OfficerGrant(A)152K—$0
Feb 1, 2024Lu Timothy KCEO and President, DirectorGrant(A)306K—$0
Feb 1, 2024Lu Timothy KCEO and President, DirectorGrant(A)459K—$0
Feb 1, 2024Rajangam KanyaChief Medical & Devt. OfficerGrant(A)101K—$0
Feb 1, 2024Rajangam KanyaChief Medical & Devt. OfficerGrant(A)152K—$0
Jun 16, 2023Mathers Edward TDirectorGrant(A)63K—$0
Jun 16, 2023Farokhzad OmidDirectorGrant(A)63K—$0
Jun 16, 2023Cooperstone BrendaDirectorGrant(A)63K—$0
Jun 16, 2023Collins James J.DirectorGrant(A)63K—$0
Jun 16, 2023Berland Susan DDirectorGrant(A)63K—$0
Feb 1, 2023Lu Timothy KCEO and President, DirectorGrant(A)630K—$0
Feb 1, 2023Rajangam KanyaChief Medical & Devt. OfficerGrant(A)130K—$0
Feb 1, 2023Knobelman DeborahChief Financial OfficerGrant(A)130K—$0
Feb 1, 2023Lee Philip JChief Technology OfficerGrant(A)195K—$0
Oct 3, 2022Knobelman DeborahChief Financial OfficerGrant(A)30K—$0
Oct 3, 2022Knobelman DeborahChief Financial OfficerGrant(A)240K—$0
Jul 18, 2022Rajangam KanyaChief Medical & Devt. OfficerGrant(A)328K—$0
Jul 13, 2022Cooperstone BrendaDirectorGrant(A)125K—$0
Jul 13, 2022Epstein David RDirectorGrant(A)125K—$0
Jul 13, 2022Berland Susan DDirectorGrant(A)125K—$0
Jul 13, 2022Farokhzad OmidDirectorGrant(A)125K—$0
Jul 13, 2022Collins James J.DirectorGrant(A)125K—$0
Jul 13, 2022Mathers Edward TDirectorGrant(A)125K—$0
Jun 8, 2022Dynamics Sponsor LLCDirector, 10% OwnerOption exercise(M)5.8M—$0
Jun 8, 2022Dynamics Sponsor LLCDirector, 10% OwnerOther(J)6.5M—$0
Jun 8, 2022Dynamics Sponsor LLCDirector, 10% OwnerOption exercise(M)5.8M——
Jun 8, 2022Farokhzad OmidDirectorOption exercise(M)5.8M—$0
Jun 8, 2022Farokhzad OmidDirectorOther(J)4.5M—$0
Jun 8, 2022Farokhzad OmidDirectorGrant(A)250K$10.00$2.5M
Jun 8, 2022Farokhzad OmidDirectorOption exercise(M)5.8M——
Jun 8, 2022Epstein David RDirectorGrant(A)113K—$0
Jun 8, 2022Epstein David RDirectorOption exercise(M)113K——

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).